BRUKER CORPORATION Professional Fees
BRUKER CORPORATION (BRKR) reported Professional Fees of $9.00 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2024-11-07
- BRUKER CORPORATION professional fees for the quarter ending 2024-09-30 was $9.00M, a 4400.00% increase year-over-year.
- BRUKER CORPORATION professional fees for the quarter ending 2023-12-31 was $100.00K.
- BRUKER CORPORATION professional fees for the quarter ending 2023-09-30 was $200.00K.
- BRUKER CORPORATION professional fees for the quarter ending 2022-03-31 was $400.00K, a 300.00% increase year-over-year.
- BRUKER CORPORATION professional fees for fiscal 2023 was $600.00K, a 75.00% decline from fiscal 2022.
- BRUKER CORPORATION professional fees for fiscal 2022 was $2.40M, a 118.18% increase from fiscal 2021.
- BRUKER CORPORATION professional fees for fiscal 2021 was $1.10M, a 81.36% decline from fiscal 2020.
- BRUKER CORPORATION professional fees for fiscal 2020 was $5.90M, a 180.95% increase from fiscal 2019.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2024-09-30 | $9.00M 10-Q · filed 2024-11-07 | $10.50M 10-Q · filed 2024-11-07 | ||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $300.00K derived: sum of 2 quarters · filed 2024-11-07 | $600.00K 10-K · filed 2024-02-29 | |
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-07 | $500.00K 10-Q · filed 2024-11-07 | ||
| 2022-12-31 | $2.40M 10-K · filed 2024-02-29 | |||
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-06 | $1.40M derived: sum of 2 quarters · filed 2024-02-29 | $1.50M derived: sum of 3 quarters · filed 2024-02-29 | $1.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.10M derived: sum of 2 quarters · filed 2024-02-29 | $1.00M derived: sum of 3 quarters · filed 2024-02-29 | $1.10M 10-K · filed 2024-02-29 |
| 2021-09-30 | $100.00K 10-Q · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $100.00K 10-Q · filed 2021-11-05 | $1.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$100.00K 10-Q · filed 2021-08-05 | $0.00 derived: sum of 2 quarters · filed 2022-05-06 | $1.10M derived: sum of 3 quarters · filed 2023-03-01 | $1.40M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-06 | $1.20M derived: sum of 2 quarters · filed 2023-03-01 | $1.50M derived: sum of 3 quarters · filed 2023-03-01 | $2.60M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.40M derived: sum of 2 quarters · filed 2023-03-01 | $2.50M derived: sum of 3 quarters · filed 2023-03-01 | $5.90M 10-K · filed 2023-03-01 |
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-05 | $1.40M derived: sum of 2 quarters · filed 2021-11-05 | $4.80M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-05 | $4.50M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $3.40M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $2.10M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $4.50M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |